Abstract
Introduction: In recent years, resting-state functional magnetic resonance imaging (rsfMRI) has been increasingly used as a noninvasive and practical method in different areas of neuroscience and psychology for recognizing brain’s mechanism as well as diagnosing neurological diseases. In this work, we use rs-fMRI data for diagnosing Alzheimer's disease.
Materials and Methods: To do that, by using the rs-fMRI of a patient, we computed the time series of some anatomical regions and then applied the Latent Low Rank Representation method to extract suitable features. Next, based on the extracted features, we apply a Support Vector Machine (SVM) classifier to determine whether the patient belongs to a healthy category, mild stage of the disease or Alzheimer's stage.
Results: The obtained classification accuracy for the proposed method is more than 97.5%.
Conclusion: We performed different experiments on a database of rs-fMRI data containing the images of 43 healthy subjects, 36 mild cognitive impairment patients and 32 Alzheimer’s patients and the obtained results demonstrated that the best performance is achieved when the SVM with Gaussian kernel and the features of only 7 regions were used.
Keywords: Functional magnetic resonance imaging (fMRI), alzheimer disease, resting-state network, latent low rank representation, SVM.
Current Signal Transduction Therapy
Title:Alzheimer Disease Diagnosis from fMRI Images Based on Latent Low Rank Features and Support Vector Machine (SVM)
Volume: 16 Issue: 2
Author(s): Nastaran Shahparian, Mehran Yazdi*Mohammad Reza Khosravi
Affiliation:
- School of Electrical and Computer Engineering, Shiraz University,Iran
Keywords: Functional magnetic resonance imaging (fMRI), alzheimer disease, resting-state network, latent low rank representation, SVM.
Abstract:
Introduction: In recent years, resting-state functional magnetic resonance imaging (rsfMRI) has been increasingly used as a noninvasive and practical method in different areas of neuroscience and psychology for recognizing brain’s mechanism as well as diagnosing neurological diseases. In this work, we use rs-fMRI data for diagnosing Alzheimer's disease.
Materials and Methods: To do that, by using the rs-fMRI of a patient, we computed the time series of some anatomical regions and then applied the Latent Low Rank Representation method to extract suitable features. Next, based on the extracted features, we apply a Support Vector Machine (SVM) classifier to determine whether the patient belongs to a healthy category, mild stage of the disease or Alzheimer's stage.
Results: The obtained classification accuracy for the proposed method is more than 97.5%.
Conclusion: We performed different experiments on a database of rs-fMRI data containing the images of 43 healthy subjects, 36 mild cognitive impairment patients and 32 Alzheimer’s patients and the obtained results demonstrated that the best performance is achieved when the SVM with Gaussian kernel and the features of only 7 regions were used.
Export Options
About this article
Cite this article as:
Shahparian Nastaran, Yazdi Mehran *, Khosravi Reza Mohammad , Alzheimer Disease Diagnosis from fMRI Images Based on Latent Low Rank Features and Support Vector Machine (SVM), Current Signal Transduction Therapy 2021; 16 (2) . https://dx.doi.org/10.2174/1574362414666191202144116
DOI https://dx.doi.org/10.2174/1574362414666191202144116 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes
Current Drug Targets Stationary Wavelet Transform and AdaBoost with SVM Based Pathological Brain Detection in MRI Scanning
CNS & Neurological Disorders - Drug Targets Survey of Latin American Neuroimmunologists on the Treatment of Multiple Sclerosis with Monoclonal Antibodies
Current Drug Safety FTY720 (Fingolimod) Ameliorates Brain Injury through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment
Current Medicinal Chemistry Biochemical Markers of Impending Psychosis
Current Pharmaceutical Design Current Status of Mucoadhesive Gel Systems for Buccal Drug Delivery
Current Pharmaceutical Design Simultaneous determination of Curcumin (Cur) and Thymoquinone (THQ) in lipid based self-nanoemulsifying systems and its application to the commercial product using UHPLC-UV-Vis spectrophotometer
Current Pharmaceutical Analysis Therapeutic Potential of Mucoadhesive Drug Delivery Systems - An Updated Patent Review
Recent Patents on Drug Delivery & Formulation Intra - and Intercellular Calcium Handling in Pulmonary Arterial Hypertension
Medicinal Chemistry Acknowledgements to Reviewers
Current Alzheimer Research Current Status of Newer Carbapenems
Current Medicinal Chemistry The IL23/Th17 Pathway as a Therapeutic Target in Chronic Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Endogenous Retroviruses in Domestic Animals
Current Genomics Editorial (Thematic Issue: Molecular Targeting for Development of Novel Therapeutic Strategies in Brain Diseases: Myth or Reality?)
CNS & Neurological Disorders - Drug Targets A Single Use Biosensor for the Detection of Nitric Oxide (NO) at ppb and sub-μM Level in Gas-and Liquid- Phase Media
Current Biomarkers (Discontinued) Regulation of Neurogenesis and Gliogenesis by Stress and Antidepressant Treatment
CNS & Neurological Disorders - Drug Targets Induction of Cytochrome P450 3A by the Ginkgo biloba Extract and Bilobalides in Human and Rat Primary Hepatocytes
Drug Metabolism Letters Metabolic Profile of Flunitrazepam: Clinical and Forensic Toxicological Aspects
Drug Metabolism Letters Non-Peptide Vasopressin V1b Receptor Antagonists as Potential Drugs for the Treatment of Stress-Related Disorders
Current Pharmaceutical Design Metric Distances between Hippocampal Shapes Indicate Different Rates of Change over Time in Nondemented and Demented Subjects
Current Alzheimer Research